
Early Detection of H&N Cancer with Lymphatic Fluid
Key highlights
- Groundbreaking study on lymphatic fluid for cancer detection
- LymphDetect™ assay shows 88% sensitivity in intermediate-risk patients
- Correlates with disease recurrence and informs adjuvant therapy decisions
- Published in Clinical Cancer Research
Source: PR Newswire
Notable Quote
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.


